# SLMAP

## Overview
The SLMAP gene encodes the sarcolemma associated protein, a family of tail-anchored membrane proteins that play a pivotal role in cellular structure and function, particularly within cardiac and skeletal muscle tissues. These proteins are characterized by structural motifs such as leucine zipper amphipathic motifs and coiled-coil domains, which facilitate protein-protein interactions and are subject to various post-translational modifications (dewan2016unique; Nader2019The). SLMAP proteins are integral components of the sarcolemma, sarcoplasmic reticulum, and other cellular membranes, where they contribute to the regulation of cardiac excitation-contraction coupling and calcium homeostasis, essential for muscle contraction and cardiovascular health (Nader2019SLMAP3; Nader2019The). The gene's expression results in multiple isoforms, including SLMAP1, SLMAP2, and SLMAP3, each with distinct roles and subcellular localizations (Rehmani2024Deletion; Nader2019SLMAP3). SLMAP's involvement in the STRIPAK complex and interactions with signaling pathways underscore its significance in modulating cardiac function and its potential implications in various cardiac and neurological disorders (Kück2019STRIPAK; Nader2019SLMAP3).

## Structure
The SLMAP (sarcolemma associated protein) gene encodes a family of tail-anchored membrane proteins characterized by several structural features. SLMAP proteins contain a leucine zipper amphipathic motif and a coiled-coil carboxyl hydrophobic segment, which are crucial for protein-protein interactions (dewan2016unique; Nader2019The). The proteins also have putative phosphorylation domains for casein kinase II, protein kinase C, and cAMP-dependent protein kinase, along with two potential glycosylation sites, indicating possible post-translational modifications (Nader2019The).

SLMAP is expressed in multiple isoforms due to alternative splicing, including SLMAP1 (~35 kDa), SLMAP2 (~45-63 kDa), and SLMAP3 (~80-95 kDa) (Rehmani2024Deletion; Nader2019SLMAP3). The longest isoform, SLMAP3, contains a forkhead-associated (FHA) domain at the N-terminal end, which targets the protein to the centrosome and mediates phosphoprotein-protein interactions (Rehmani2024Deletion; Nader2019The). SLMAP isoforms express one of two identified transmembrane domains (TM1 or TM2), which target the proteins to different subcellular organelles such as the sarcolemma, sarcoplasmic/endoplasmic reticulum, and mitochondria (dewan2016unique; Nader2019SLMAP3). The TM2 domain has a unique hydrophobic profile, allowing integration into various membranes (dewan2016unique).

## Function
The SLMAP gene encodes a family of tail-anchored membrane proteins that play a crucial role in cardiac and skeletal muscle function. In healthy human cells, SLMAP is involved in the regulation of cardiac excitation-contraction (E-C) coupling, a process essential for heart function. It is active in the sarcoplasmic reticulum, sarcolemma, and nuclear envelope, where it influences calcium homeostasis, impacting muscle contraction and overall cardiovascular health (Nader2019SLMAP3; Nader2019The).

SLMAP proteins, particularly the SLMAP-3 isoform, interact with striatin, a regulator of cardiomyocyte contraction, and are part of the STRIPAK complex, which includes kinases and phosphatases. This interaction suggests a role in modulating cardiomyocyte function through adrenergic signaling pathways, enhancing the response to adrenergic stimuli by increasing intracellular calcium levels (Nader2019SLMAP3).

SLMAP is also involved in the organization of cardiac membranes, influencing the morphology of transverse tubules and the sarcoplasmic reticulum. Its presence in cardiac membranes, but not the cytosol, implies a role in organizing these structures and coordinating their function, which is vital for maintaining proper myocardial contraction and preventing cardiac failure (Nader2019The).

## Clinical Significance
Mutations or altered expression of the SLMAP gene have been implicated in several cardiac conditions, including arrhythmias and cardiomyopathy. These conditions arise due to disruptions in the normal function of SLMAP, which plays a critical role in ion channel regulation and intracellular trafficking. Such disruptions can lead to improper cardiac muscle function and electrical signaling, contributing to the development of these heart diseases.

In addition to cardiac implications, alterations in SLMAP interactions may also be associated with neurological disorders. The precise mechanisms are not fully understood, but it is suggested that SLMAP's role in cellular processes could affect neural function when its expression or interactions are disrupted. This could potentially lead to various neurological symptoms or conditions.

SLMAP has also been linked to metabolic syndromes. Changes in its expression or function might influence metabolic pathways, although the exact pathways and outcomes require further investigation. The involvement of SLMAP in these diverse conditions highlights its importance in maintaining cellular homeostasis and the potential consequences of its dysregulation.

## Interactions
SLMAP (sarcolemma associated protein) is involved in various protein interactions, playing a significant role in cellular processes. It is a component of the STRIPAK complex, a conserved multiprotein complex that includes striatin, MOB3, and PP2A subunits. In this complex, SLMAP interacts with striatin, which is crucial for regulating cardiac contraction through adenylyl cyclase pathways (Kück2019STRIPAK; Nader2019SLMAP3). SLMAP's interaction with striatin is significant in cardiomyocytes, where it modulates cardiac function by affecting intracellular calcium levels and adrenergic signaling pathways (Nader2019SLMAP3).

SLMAP also interacts with the Hippo pathway by binding to an FHA domain, which recruits SAV1 to the STRIPAK core, enabling the regulation of phosphatase activity. This interaction is crucial for the dephosphorylation of key kinases and their activators, impacting cellular signaling pathways (Kück2019STRIPAK). Additionally, SLMAP is involved in the trafficking of sodium channels, influencing electrophysiological properties in cardiomyocytes, and is linked to conditions such as Brugada syndrome (Nader2019The). These interactions highlight SLMAP's role in both structural and signaling functions within cells.


## References


1. (dewan2016unique) Aaraf Dewan. A Unique Role for Sarcolemmal Membrane Associated Protein Isoform 1 (SLMAP1) as a Regulator of Cardiac Metabolism and Endosomal Recycling. PhD thesis, Université d'Ottawa/University of Ottawa, 2016. This article has 1 citations.

[2. (Kück2019STRIPAK) Ulrich Kück, Daria Radchenko, and Ines Teichert. Stripak, a highly conserved signaling complex, controls multiple eukaryotic cellular and developmental processes and is linked with human diseases. Biological Chemistry, 400(8):1005–1022, May 2019. URL: http://dx.doi.org/10.1515/hsz-2019-0173, doi:10.1515/hsz-2019-0173. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2019-0173)

[3. (Nader2019SLMAP3) Moni Nader, Ebtehal Alsolme, Shahd Alotaibi, Rahmah Alsomali, Dana Bakheet, and Nduna Dzimiri. Slmap-3 is downregulated in human dilated ventricles and its overexpression promotes cardiomyocyte response to adrenergic stimuli by increasing intracellular calcium. Canadian Journal of Physiology and Pharmacology, 97(7):623–630, July 2019. URL: http://dx.doi.org/10.1139/cjpp-2018-0660, doi:10.1139/cjpp-2018-0660. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1139/cjpp-2018-0660)

[4. (Rehmani2024Deletion) Taha Rehmani, Ana Paula Dias, Marsel Kamal, Maysoon Salih, and Balwant S. Tuana. Deletion of sarcolemmal membrane-associated protein isoform 3 (slmap3) in cardiac progenitors delays embryonic growth of myocardium without affecting hippo pathway. International Journal of Molecular Sciences, 25(5):2888, March 2024. URL: http://dx.doi.org/10.3390/ijms25052888, doi:10.3390/ijms25052888. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25052888)

[5. (Nader2019The) Moni Nader. The slmap/striatin complex: an emerging regulator of normal and abnormal cardiac excitation-contraction coupling. European Journal of Pharmacology, 858:172491, September 2019. URL: http://dx.doi.org/10.1016/j.ejphar.2019.172491, doi:10.1016/j.ejphar.2019.172491. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.ejphar.2019.172491)